USA & Canada

Aspen Canada was founded in 2014 to support our products distributed in this region. The development of our complex API capabilities into niche FDF offerings represents an opportunity for future product launches in the United States. Our satellite API facility in Sioux City supports the Oss site in supplying APIs worldwide.

Key Countries

Canada,
USA

Contribution to Group revenue

Revenue contribution - by therapeutic category

In the US, growth in total medicine spending net of rebates, discounts and other price concessions increased 4,5% to USD344 billion
The volume of the United States prescription pharmaceutical market grew 2,7% in 2018
Canada is the 10th largest pharmaceutical market with brand-name products accounting for 78% of sales

Source: December 2018 IQVIA and IQVIA Pharmafocus 2021

STATISTICS

Number of products launched:

Nil

(2018: 1)^#

In-market sales value of pipeline as at 30 June 2019 anticipated to be launched in:

0 – 2 years

USD1 103 million

3 – 5 years

USD1 210 million

Number of product recalls:

1

(2018: Nil)

Average staff turnover:

19,2%

(2018: 25,4%)

Number of work-related fatalities:

Nil

(2018: Nil)

Number of permanent employees:

^# The number of product launches has been restated to take into account discontinued operations.

Revenue	2019 R’million	2018 (CER) R’million	change %
Total	675	693	(3)
Regional Brands	340	364	(7)
Sterile Focus Brands	355	329	2
Anaesthetics Brands	321	321	0
Thrombosis Brands	14	8	(54)

Note: Commercial Pharmaceuticals revenue is disclosed by customer geography.